Cargando…

HIF in Gastric Cancer: Regulation and Therapeutic Target

HIF means hypoxia-inducible factor gene family, and it could regulate various biological processes, including tumor development. In 2021, the FDA approved the new drug Welireg for targeting HIF-2a, and it is mainly used to treat von Hippel-Lindau syndrome, which demonstrated its good prospects in tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mengqing, Li, Guan, Yang, Xiaodong, Yin, Weihua, Lv, Guoqing, Wang, Shubin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370240/ https://www.ncbi.nlm.nih.gov/pubmed/35956843 http://dx.doi.org/10.3390/molecules27154893

Ejemplares similares

Circular RNAs in Gastric Cancer: Potential Biomarkers and Therapeutic Targets
por: Ouyang, Jiafeng, et al.
Publicado: (2020)

Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target
por: Infantino, Vittoria, et al.
Publicado: (2021)

HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential
por: Li, Siyao, et al.
Publicado: (2021)

miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
por: Serocki, Marcin, et al.
Publicado: (2018)

Regulation of Transactivation at C-TAD Domain of HIF-1α by Factor-Inhibiting HIF-1α (FIH-1): A Potential Target for Therapeutic Intervention in Cancer
por: Rani, Soniya, et al.
Publicado: (2022)

Low-Temperature Plasma-Activated Medium Inhibited Proliferation and Progression of Lung Cancer by Targeting the PI3K/Akt and MAPK Pathways
por: Li, Ying, et al.
Publicado: (2022)

Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study
por: Tong, Gangling, et al.
Publicado: (2020)

The Critical Impact of HIF-1α on Gastric Cancer Biology
por: Kitajima, Yoshihiko, et al.
Publicado: (2013)

Altered Expression of Hypoxia-Inducible Factor-1α (HIF-1α) and Its Regulatory Genes in Gastric Cancer Tissues
por: Wang, Jihan, et al.
Publicado: (2014)

The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer
por: Ucaryilmaz Metin, Cemre, et al.
Publicado: (2022)

Identification of New Therapeutic Targets for Gastric Cancer With Bioinformatics
por: Li, Yang, et al.
Publicado: (2020)

Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
por: Samec, Marek, et al.
Publicado: (2021)

HIF-1α pathway: role, regulation and intervention for cancer therapy
por: Masoud, Georgina N., et al.
Publicado: (2015)

Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development
por: Ghosh, Rituparna, et al.
Publicado: (2022)

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
por: Badie, Amandine, et al.
Publicado: (2022)

Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy
por: Zhang, Minghui, et al.
Publicado: (2022)

Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy
por: Davis, Leah, et al.
Publicado: (2022)

MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation
por: Liu, L, et al.
Publicado: (2016)

MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation
por: Liu, L, et al.
Publicado: (2017)

Plasminogen kringle 5 suppresses gastric cancer via regulating HIF-1α and GRP78
por: Fang, Shuhuan, et al.
Publicado: (2017)

HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia
por: Guo, Wancheng, et al.
Publicado: (2022)

Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies
por: Farkhondeh, Tahereh, et al.
Publicado: (2021)

Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer
por: Tsai, Ming-Ming, et al.
Publicado: (2016)

Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
por: Li, Tiansheng, et al.
Publicado: (2020)

Hypoxia regulates RNA splicing of HIF targets
por: Hu, Cheng-Jun
Publicado: (2014)

The origin of gastric cancer stem cells and their effects on gastric cancer: Novel therapeutic targets for gastric cancer
por: Yang, Ying, et al.
Publicado: (2022)

Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer
por: Huang, Yi, et al.
Publicado: (2016)

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
por: Xu, Da-zhi, et al.
Publicado: (2010)

Autophagy in Gastric Mucosa: The Dual Role and Potential Therapeutic Target
por: Lu, Sheng-Yu, et al.
Publicado: (2021)

Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets
por: Serebrovska, Zoya O., et al.
Publicado: (2020)

AMPK: a therapeutic target of heart failure—not only metabolism regulation
por: Li, Xuan, et al.
Publicado: (2019)

Targeting Protein–Protein Interactions in the HIF System
por: Wilkins, Sarah E., et al.
Publicado: (2016)

SOX8 promotes tumor growth and metastasis through FZD6-dependent Wnt/β-catenin signaling in colorectal carcinoma
por: Li, Chen, et al.
Publicado: (2023)

Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
por: Inokuchi, Mikito, et al.
Publicado: (2015)

PVT1/miR-16/CCND1 axis regulates gastric cancer progression
por: Lv, Haidong, et al.
Publicado: (2023)

Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma
por: Li, Fengzhi, et al.
Publicado: (2021)

Novel Therapeutic Targets for Hypoxia-Related Cardiovascular Diseases: The Role of HIF-1
por: Liu, Minxuan, et al.
Publicado: (2020)

Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance
por: Mazumder, Sonia, et al.
Publicado: (2023)

MicroRNA-424 regulates cisplatin resistance of gastric cancer by targeting SMURF1 based on GEO database and primary validation in human gastric cancer tissues
por: Lu, Li, et al.
Publicado: (2019)

Therapeutic Targeting of TP53-mutated Acute Myeloid Leukemia by Inhibiting HIF-1α with Echinomycin
por: Wang, Yin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v13787igitasd4f8quif5ugmhe